Will DOJ confirm no appeal of CVS opioid settlement by 13 Dec 2026?
Avaldatud 2026-10-14 — 60 päeva enne tähtaega, väidetud enne tulemuse selgumist.
The U.S. Department of Justice oversees federal litigation involving public health and corporate liability. CVS Health is a major American pharmacy and healthcare services company. This question concerns the legal finality of a specific financial resolution related to opioid distribution claims.
Väide
By 2026-12-13, the U.S. Department of Justice will announce that it has not filed a motion for reconsideration or appeal regarding the CVS Health opioid settlement, confirming the finality of the $315 million resolution.
Põhjendusahel
- CVS agreed to pay $315 million to settle the DOJ opioid prescription case as of October 14, 2026
- Settlement agreements in DOJ civil cases typically require formal court filings and judicial approval within weeks of announcement
- DOJ will file the consent decree or settlement documents in federal court to finalize the agreement
Tõendid seni
0 kinnitavat · 0 ümberlükkavat signaali · 0 kinnitust · 0 murtud eeldust. Tõendid ise on osa täisdossiest.
Tõenäosuse ajalugu
Uuendatud 1 kord alates lisamisest (viimati 2026-10-14) — 77% alguses → 82% täna.
Mida jälgida
- eeltingimus The DOJ files the proposed consent decree or settlement agreement with the federal court clerk in the CVS Health opioid case
- juhtnäitaja The court docket reflects a notice of proposed settlement or a scheduled hearing for judicial approval of the CVS Health opioid settlement
- verstapost The DOJ files the CVS Health opioid settlement consent decree in the relevant federal district court
Selle ennustuse taga olev täisdossier — tõendite jälg, riskianalüüs, rahastamisstsenaariumid — on saadaval soovi korral: [email protected].
Tõenäosused on kalibreeritud süsteemi enda lahendatud ajaloo põhjal; pärast tähtaega tulemus lahendatakse ja auditeeritakse — kaasa arvatud need, milles me eksisime. Miski sellel lehel ei ole investeerimisnõuanne.